Yun Teng

Title: Innovations of Yun Teng in Pharmaceutical Development

Introduction

Yun Teng is a notable inventor based in Taizhou, China, recognized for his contributions to the pharmaceutical industry. He has been instrumental in developing methods for producing important compounds used in various medical applications. With a total of two patents to his name, his work has significantly impacted the field of microbiology and pharmacology.

Latest Patents

Yun Teng's latest patents include innovative methods for producing milbemycin A4 and milbemycin A3. The first patent involves a strain of Streptomyces, specifically HS7522, which is deposited in the China General Microbiological Culture Collection Center under the accession number CGMCC No. 9671 as of September 16, 2014. This method outlines the process of culturing the strain to produce milbemycin A4 effectively. The second patent features another strain, HS7523, also deposited in the same center with the accession number CGMCC No. 9672 on the same date. This patent describes a method for preparing milbemycin A3 through similar culturing techniques.

Career Highlights

Yun Teng is currently associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the development of pharmaceutical products. His work at the company has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of Yun Teng's notable coworkers include Meidong Xu and Meiyi Mo. Their collaborative efforts have further advanced the research and development initiatives within their organization.

Conclusion

Yun Teng's contributions to the pharmaceutical industry through his patents and collaborative work highlight his role as an influential inventor. His innovative methods for producing milbemycin compounds demonstrate the importance of research in developing effective medical treatments.